Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
Recruiting · NCT06984822 · Registry updated 2025-11-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant | Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Visual Impairment, diabetes mellitus, diabetic macular edema, endocrine system disorder, eye disorder, glucose metabolism disease, hyperglycemia, metabolic disease, nervous system disorder, vision disorder | Recruiting | Not applicable | 2025-11-21 | NCT06984822 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vastra Gotaland Region | 163 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sahlgrenska University Hospital, Department of Ophthalmology | Mölndal | Sweden | 1 |
| Ögonmottagning Mölndal/SU | Mölndal | Sweden | 2 |